This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
MilliporeSigma
other brands :
FLUKA, Sigma-Aldrich, Roche Applied Science
product type :
chemical
product name :
(±)-6-Chloro-PB hydrobromide
catalog :
S143
citations: 30
Reference
Bouchet C, Miner M, Loetz E, Rosberg A, Hake H, Farmer C, et al. Activation of Nigrostriatal Dopamine Neurons during Fear Extinction Prevents the Renewal of Fear. Neuropsychopharmacology. 2017;: pubmed publisher
Gore B, Zweifel L. Genetic reconstruction of dopamine D1 receptor signaling in the nucleus accumbens facilitates natural and drug reward responses. J Neurosci. 2013;33:8640-9 pubmed publisher
Ericsson J, Stephenson Jones M, Pérez Fernández J, Robertson B, Silberberg G, Grillner S. Dopamine differentially modulates the excitability of striatal neurons of the direct and indirect pathways in lamprey. J Neurosci. 2013;33:8045-54 pubmed publisher
Planert H, Berger T, Silberberg G. Membrane properties of striatal direct and indirect pathway neurons in mouse and rat slices and their modulation by dopamine. PLoS ONE. 2013;8:e57054 pubmed publisher
Olianas M, Dedoni S, Onali P. Potentiation of dopamine D1-like receptor signaling by concomitant activation of ?- and ?-opioid receptors in mouse medial prefrontal cortex. Neurochem Int. 2012;61:1404-16 pubmed publisher
Gangarossa G, Valjent E. Regulation of the ERK pathway in the dentate gyrus by in vivo dopamine D1 receptor stimulation requires glutamatergic transmission. Neuropharmacology. 2012;63:1107-17 pubmed publisher
Hodas J, Nehring A, Höche N, Sweredoski M, Pielot R, Hess S, et al. Dopaminergic modulation of the hippocampal neuropil proteome identified by bioorthogonal noncanonical amino acid tagging (BONCAT). Proteomics. 2012;12:2464-76 pubmed publisher
Nikiforuk A. Dopamine D1 receptor modulation of set shifting: the role of stress exposure. Behav Pharmacol. 2012;23:434-8 pubmed publisher
Bradbury S, Gittings D, Schenk S. Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D₁- and D₂-like agonists. Psychopharmacology (Berl). 2012;223:389-99 pubmed
Knab A, Bowen R, Hamilton A, Lightfoot J. Pharmacological manipulation of the dopaminergic system affects wheel-running activity in differentially active mice. J Biol Regul Homeost Agents. 2012;26:119-29 pubmed
Gangarossa G, Perroy J, Valjent E. Combinatorial topography and cell-type specific regulation of the ERK pathway by dopaminergic agonists in the mouse striatum. Brain Struct Funct. 2013;218:405-19 pubmed publisher
Kawamoto K, Otsuguro K, Ishizuka M, Ito S. Inhibitory effects of dopamine on spinal synaptic transmission via dopamine D1-like receptors in neonatal rats. Br J Pharmacol. 2012;166:788-800 pubmed publisher
Hoque K, West A. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens. Synapse. 2012;66:220-31 pubmed publisher
Krishnan B, Genzer K, Pollandt S, Liu J, Gallagher J, Shinnick Gallagher P. Dopamine-induced plasticity, phospholipase D (PLD) activity and cocaine-cue behavior depend on PLD-linked metabotropic glutamate receptors in amygdala. PLoS ONE. 2011;6:e25639 pubmed publisher
KOTOWSKI S, Hopf F, Seif T, Bonci A, von Zastrow M. Endocytosis promotes rapid dopaminergic signaling. Neuron. 2011;71:278-90 pubmed publisher
Krawczyk M, Sharma R, Mason X, Debacker J, Jones A, Dumont E. A switch in the neuromodulatory effects of dopamine in the oval bed nucleus of the stria terminalis associated with cocaine self-administration in rats. J Neurosci. 2011;31:8928-35 pubmed publisher
St Onge J, Abhari H, Floresco S. Dissociable contributions by prefrontal D1 and D2 receptors to risk-based decision making. J Neurosci. 2011;31:8625-33 pubmed publisher
Ohmura Y, Jutkiewicz E, Zhang A, Domino E. Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats. Pharmacol Biochem Behav. 2011;99:552-6 pubmed publisher
Gangarossa G, Di Benedetto M, O Sullivan G, Dunleavy M, Alcacer C, Bonito Oliva A, et al. Convulsant doses of a dopamine D1 receptor agonist result in Erk-dependent increases in Zif268 and Arc/Arg3.1 expression in mouse dentate gyrus. PLoS ONE. 2011;6:e19415 pubmed publisher
Dupre K, Ostock C, Eskow Jaunarajs K, Button T, Savage L, Wolf W, et al. Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats. Exp Neurol. 2011;229:288-99 pubmed publisher
Fiorentini C, Mattanza C, Collo G, Savoia P, Spano P, Missale C. The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. J Neurochem. 2011;117:253-63 pubmed publisher
Reichart D, Hinkle R, Lefever F, Dolan E, Dietrich J, Sibley D, et al. Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions. BMC Musculoskelet Disord. 2011;12:27 pubmed publisher
Jürgensen S, Antonio L, Mussi G, Brito Moreira J, Bomfim T, De Felice F, et al. Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers. J Biol Chem. 2011;286:3270-6 pubmed publisher
Madsen M, Peacock L, Werge T, Andersen M, Andreasen J. Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys. Neuropharmacology. 2011;60:418-22 pubmed publisher
Mizoguchi K, Shoji H, Tanaka Y, Tabira T. Orbitofrontal dopaminergic dysfunction causes age-related impairment of reversal learning in rats. Neuroscience. 2010;170:1110-9 pubmed publisher
Momiyama T. Developmental increase in D1-like dopamine receptor-mediated inhibition of glutamatergic transmission through P/Q-type channel regulation in the basal forebrain of rats. Eur J Neurosci. 2010;32:579-90 pubmed publisher
Yuan J, Johnson R, Huang R, Wichterman J, Jiang H, Hayton K, et al. Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol. 2009;5:765-71 pubmed publisher
Andersen P, Jansen J. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy. Eur J Pharmacol. 1990;188:335-47 pubmed
Johansen P, Hu X, White F. Relationship between D1 dopamine receptors, adenylate cyclase, and the electrophysiological responses of rat nucleus accumbens neurons. J Neural Transm Gen Sect. 1991;86:97-113 pubmed
Arnt J, Hyttel J, Sanchez C. Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur J Pharmacol. 1992;213:259-67 pubmed
product information
Catalog Number :
S143
Product Name :
(±)-6-Chloro-PB hydrobromide
Product Type :
SMALL MOLECULES
Product Group :
Protein & Pathway Technologies
Product Description :
≥98% (HPLC), solid
company information
MilliporeSigma
PO Box 14508
St. Louis, MO 63178
https://www.sigmaaldrich.com
1-800-325-3010
headquarters: USA